date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.712254931742946.
The log-likelihood improved by 2.884.
Iteration 2 of at most 500:
Optimizing with step length 0.691963303389346.
The log-likelihood improved by 1.98.
Iteration 3 of at most 500:
Optimizing with step length 0.939569932315293.
The log-likelihood improved by 2.458.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.6089.
Step length converged once. Increasing MCMC sample size.
Iteration 5 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.4023.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       15     1192     1052      791      357      366      369 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     308      229      144       84       48       20       11        7 
degree16 degree17 
       2        1 
1 
disease_progression 
H-positive risk:  899 887 118 846 423 130 912 444 102 56 124 59 
H-negative risk:  887 899 912 846 444 423 130 118 124 102 59 56 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
48 new agents 
2 
disease_progression 
H-positive risk:  907 888 118 845 419 130 913 440 100 56 125 59 
H-negative risk:  888 907 913 845 440 419 130 118 125 100 59 56 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
3 
disease_progression 
H-positive risk:  907 894 117 845 415 131 912 439 101 54 127 58 
H-negative risk:  894 907 912 845 439 415 131 117 127 101 58 54 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
4 
disease_progression 
H-positive risk:  915 895 117 840 413 130 913 435 102 54 128 58 
H-negative risk:  895 915 913 840 435 413 130 117 128 102 58 54 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 3 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
5 
disease_progression 
H-positive risk:  922 902 119 838 402 131 912 430 102 53 129 60 
H-negative risk:  902 922 912 838 430 402 131 119 129 102 60 53 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 4 2 

clinical_engagement 
diagnosis 
demography 
53 new agents 
6 
disease_progression 
H-positive risk:  924 910 120 839 400 133 907 421 106 53 127 60 
H-negative risk:  910 924 907 839 421 400 133 120 127 106 60 53 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 7 5 

clinical_engagement 
diagnosis 
demography 
45 new agents 
7 
disease_progression 
H-positive risk:  929 913 120 833 404 131 901 421 106 55 127 60 
H-negative risk:  913 929 901 833 421 404 131 120 127 106 60 55 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 8 6 

clinical_engagement 
diagnosis 
demography 
54 new agents 
8 
disease_progression 
H-positive risk:  937 912 120 836 400 133 899 410 110 55 128 60 
H-negative risk:  912 937 899 836 410 400 133 120 128 110 60 55 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 8 6 

clinical_engagement 
diagnosis 
demography 
63 new agents 
9 
disease_progression 
H-positive risk:  939 918 121 833 397 133 893 415 110 55 126 60 
H-negative risk:  918 939 893 833 415 397 133 121 126 110 60 55 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 9 7 

clinical_engagement 
diagnosis 
demography 
65 new agents 
10 
disease_progression 
H-positive risk:  943 919 122 833 392 135 899 415 107 54 123 58 
H-negative risk:  919 943 899 833 415 392 135 122 123 107 58 54 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 10 8 

clinical_engagement 
diagnosis 
demography 
70 new agents 
11 
disease_progression 
H-positive risk:  946 919 124 832 392 139 895 417 105 54 121 56 
H-negative risk:  919 946 895 832 417 392 139 124 121 105 56 54 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 10 8 

clinical_engagement 
diagnosis 
demography 
49 new agents 
12 
disease_progression 
H-positive risk:  947 926 128 834 385 137 894 413 105 55 120 56 
H-negative risk:  926 947 894 834 413 385 137 128 120 105 56 55 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 13 9 

clinical_engagement 
diagnosis 
demography 
64 new agents 
13 
disease_progression 
H-positive risk:  866 849 117 908 384 122 983 414 119 53 130 55 
H-negative risk:  849 866 983 908 414 384 122 117 130 119 55 53 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 17 11 

clinical_engagement 
diagnosis 
demography 
203 new agents 
14 
disease_progression 
H-positive risk:  894 888 122 865 385 129 938 426 117 55 117 64 
H-negative risk:  888 894 938 865 426 385 129 122 117 117 64 55 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 18 16 

clinical_engagement 
diagnosis 
demography 
54 new agents 
15 
disease_progression 
H-positive risk:  896 891 121 870 381 129 936 425 117 55 117 62 
H-negative risk:  891 896 936 870 425 381 129 121 117 117 62 55 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 18 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
16 
disease_progression 
H-positive risk:  900 893 122 868 375 130 940 423 116 56 118 59 
H-negative risk:  893 900 940 868 423 375 130 122 118 116 59 56 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 19 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
17 
disease_progression 
H-positive risk:  901 897 122 863 374 131 937 425 114 58 119 59 
H-negative risk:  897 901 937 863 425 374 131 122 119 114 59 58 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 20 15 

clinical_engagement 
diagnosis 
demography 
57 new agents 
18 
disease_progression 
H-positive risk:  910 899 123 854 377 134 938 420 112 57 118 58 
H-negative risk:  899 910 938 854 420 377 134 123 118 112 58 57 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 22 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
19 
disease_progression 
H-positive risk:  912 903 123 855 374 134 934 417 114 59 117 58 
H-negative risk:  903 912 934 855 417 374 134 123 117 114 58 59 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 25 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
20 
disease_progression 
H-positive risk:  911 910 124 857 375 136 928 410 118 58 117 56 
H-negative risk:  910 911 928 857 410 375 136 124 117 118 56 58 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 27 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
21 
disease_progression 
H-positive risk:  912 916 124 855 373 136 926 411 119 57 117 54 
H-negative risk:  916 912 926 855 411 373 136 124 117 119 54 57 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 29 13 

clinical_engagement 
diagnosis 
demography 
56 new agents 
22 
disease_progression 
H-positive risk:  917 918 125 848 375 137 930 405 120 56 116 53 
H-negative risk:  918 917 930 848 405 375 137 125 116 120 53 56 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 32 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
23 
disease_progression 
H-positive risk:  922 920 125 852 366 136 934 401 121 54 116 53 
H-negative risk:  920 922 934 852 401 366 136 125 116 121 53 54 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 32 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
24 
disease_progression 
H-positive risk:  922 922 124 855 361 137 933 395 121 56 120 54 
H-negative risk:  922 922 933 855 395 361 137 124 120 121 54 56 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 33 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
25 
disease_progression 
H-positive risk:  862 856 112 921 352 128 1004 396 131 56 130 52 
H-negative risk:  856 862 1004 921 396 352 128 112 130 131 52 56 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 35 15 

clinical_engagement 
diagnosis 
demography 
198 new agents 
26 
disease_progression 
H-positive risk:  881 879 114 880 360 132 974 415 128 61 124 52 
H-negative risk:  879 881 974 880 415 360 132 114 124 128 52 61 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 34 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
27 
disease_progression 
H-positive risk:  885 890 115 879 352 131 968 415 127 62 125 51 
H-negative risk:  890 885 968 879 415 352 131 115 125 127 51 62 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 35 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
28 
disease_progression 
H-positive risk:  892 894 115 879 349 129 972 404 127 64 125 50 
H-negative risk:  894 892 972 879 404 349 129 115 125 127 50 64 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 34 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
29 
disease_progression 
H-positive risk:  902 895 115 876 347 126 969 400 129 65 125 51 
H-negative risk:  895 902 969 876 400 347 126 115 125 129 51 65 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 35 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
30 
disease_progression 
H-positive risk:  904 891 114 879 341 126 970 405 128 64 129 49 
H-negative risk:  891 904 970 879 405 341 126 114 129 128 49 64 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 36 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
31 
disease_progression 
H-positive risk:  911 891 116 880 339 128 969 399 127 65 128 47 
H-negative risk:  891 911 969 880 399 339 128 116 128 127 47 65 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 39 17 

clinical_engagement 
diagnosis 
demography 
55 new agents 
32 
disease_progression 
H-positive risk:  914 895 116 883 339 127 970 391 127 60 129 49 
H-negative risk:  895 914 970 883 391 339 127 116 129 127 49 60 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 39 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
33 
disease_progression 
H-positive risk:  923 898 116 877 333 126 969 395 125 59 129 50 
H-negative risk:  898 923 969 877 395 333 126 116 129 125 50 59 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 41 17 

clinical_engagement 
diagnosis 
demography 
56 new agents 
34 
disease_progression 
H-positive risk:  927 902 116 878 332 127 969 389 123 56 130 51 
H-negative risk:  902 927 969 878 389 332 127 116 130 123 51 56 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 41 16 

clinical_engagement 
diagnosis 
demography 
58 new agents 
35 
disease_progression 
H-positive risk:  933 900 119 881 324 126 969 386 121 57 133 51 
H-negative risk:  900 933 969 881 386 324 126 119 133 121 51 57 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 44 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
36 
disease_progression 
H-positive risk:  944 902 120 876 321 128 967 383 122 54 132 51 
H-negative risk:  902 944 967 876 383 321 128 120 132 122 51 54 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 44 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
37 
disease_progression 
H-positive risk:  891 847 114 921 315 123 1030 377 131 57 143 51 
H-negative risk:  847 891 1030 921 377 315 123 114 143 131 51 57 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 46 21 

clinical_engagement 
diagnosis 
demography 
154 new agents 
38 
disease_progression 
H-positive risk:  901 860 117 883 330 125 993 417 130 53 135 56 
H-negative risk:  860 901 993 883 417 330 125 117 135 130 56 53 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 44 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
39 
disease_progression 
H-positive risk:  899 860 118 887 332 127 984 421 130 52 137 53 
H-negative risk:  860 899 984 887 421 332 127 118 137 130 53 52 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 44 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
40 
disease_progression 
H-positive risk:  894 861 118 881 335 130 989 413 133 55 137 54 
H-negative risk:  861 894 989 881 413 335 130 118 137 133 54 55 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 45 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
41 
disease_progression 
H-positive risk:  889 863 119 884 335 128 993 406 137 56 136 54 
H-negative risk:  863 889 993 884 406 335 128 119 136 137 54 56 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 46 20 

clinical_engagement 
diagnosis 
demography 
52 new agents 
42 
disease_progression 
H-positive risk:  894 867 119 883 337 129 985 405 138 56 135 52 
H-negative risk:  867 894 985 883 405 337 129 119 135 138 52 56 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 44 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
43 
disease_progression 
H-positive risk:  896 872 117 881 339 128 986 397 142 54 136 52 
H-negative risk:  872 896 986 881 397 339 128 117 136 142 52 54 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 45 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
44 
disease_progression 
H-positive risk:  898 875 117 885 332 129 985 395 142 56 134 52 
H-negative risk:  875 898 985 885 395 332 129 117 134 142 52 56 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 46 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
45 
disease_progression 
H-positive risk:  900 872 118 882 329 132 988 394 140 56 138 51 
H-negative risk:  872 900 988 882 394 329 132 118 138 140 51 56 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 49 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
46 
disease_progression 
H-positive risk:  900 877 119 883 328 134 987 387 139 56 140 50 
H-negative risk:  877 900 987 883 387 328 134 119 140 139 50 56 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 51 21 

clinical_engagement 
diagnosis 
demography 
57 new agents 
47 
disease_progression 
H-positive risk:  900 881 118 882 323 136 991 387 138 56 138 50 
H-negative risk:  881 900 991 882 387 323 136 118 138 138 50 56 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
48 
disease_progression 
H-positive risk:  902 884 117 875 325 135 997 383 137 57 140 48 
H-negative risk:  884 902 997 875 383 325 135 117 140 137 48 57 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 53 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
49 
disease_progression 
H-positive risk:  852 825 112 939 327 123 1046 379 152 56 141 48 
H-negative risk:  825 852 1046 939 379 327 123 112 141 152 48 56 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 51 20 

clinical_engagement 
diagnosis 
demography 
145 new agents 
50 
disease_progression 
H-positive risk:  859 835 115 917 330 127 1022 403 155 53 140 44 
H-negative risk:  835 859 1022 917 403 330 127 115 140 155 44 53 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
51 
disease_progression 
H-positive risk:  864 836 116 916 329 128 1009 412 151 53 142 44 
H-negative risk:  836 864 1009 916 412 329 128 116 142 151 44 53 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 56 21 

clinical_engagement 
diagnosis 
demography 
57 new agents 
52 
disease_progression 
H-positive risk:  872 839 116 908 333 127 1001 412 154 53 140 45 
H-negative risk:  839 872 1001 908 412 333 127 116 140 154 45 53 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 57 23 

clinical_engagement 
diagnosis 
demography 
57 new agents 
53 
disease_progression 
H-positive risk:  880 841 115 906 329 128 991 419 153 56 136 46 
H-negative risk:  841 880 991 906 419 329 128 115 136 153 46 56 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 58 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
54 
disease_progression 
H-positive risk:  879 850 119 908 321 128 986 420 149 58 135 47 
H-negative risk:  850 879 986 908 420 321 128 119 135 149 47 58 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 58 21 

clinical_engagement 
diagnosis 
demography 
47 new agents 
55 
disease_progression 
H-positive risk:  874 846 120 914 321 128 984 421 150 58 136 48 
H-negative risk:  846 874 984 914 421 321 128 120 136 150 48 58 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 59 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
56 
disease_progression 
H-positive risk:  872 856 123 905 320 125 986 418 151 58 138 48 
H-negative risk:  856 872 986 905 418 320 125 123 138 151 48 58 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 60 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
57 
disease_progression 
H-positive risk:  879 864 121 897 329 124 983 412 152 54 137 48 
H-negative risk:  864 879 983 897 412 329 124 121 137 152 48 54 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 60 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
58 
disease_progression 
H-positive risk:  874 863 122 897 332 124 981 416 154 54 136 47 
H-negative risk:  863 874 981 897 416 332 124 122 136 154 47 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 60 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
59 
disease_progression 
H-positive risk:  873 859 119 892 334 122 988 414 159 56 140 44 
H-negative risk:  859 873 988 892 414 334 122 119 140 159 44 56 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 61 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
60 
disease_progression 
H-positive risk:  873 868 117 894 337 122 991 406 154 57 139 42 
H-negative risk:  868 873 991 894 406 337 122 117 139 154 42 57 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 62 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
61 
disease_progression 
H-positive risk:  822 818 108 957 333 108 1051 399 165 54 142 43 
H-negative risk:  818 822 1051 957 399 333 108 108 142 165 43 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 62 25 

clinical_engagement 
diagnosis 
demography 
107 new agents 
62 
disease_progression 
H-positive risk:  820 829 108 924 356 107 1029 425 167 54 136 45 
H-negative risk:  829 820 1029 924 425 356 107 108 136 167 45 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
63 
disease_progression 
H-positive risk:  827 831 111 928 354 110 1019 424 162 54 134 46 
H-negative risk:  831 827 1019 928 424 354 110 111 134 162 46 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 62 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
64 
disease_progression 
H-positive risk:  836 839 113 916 355 110 1014 420 163 55 133 46 
H-negative risk:  839 836 1014 916 420 355 110 113 133 163 46 55 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 63 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
65 
disease_progression 
H-positive risk:  834 840 112 925 351 108 1010 425 164 54 132 45 
H-negative risk:  840 834 1010 925 425 351 108 112 132 164 45 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
66 
disease_progression 
H-positive risk:  845 838 113 926 348 110 1013 414 164 52 133 44 
H-negative risk:  838 845 1013 926 414 348 110 113 133 164 44 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 66 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
67 
disease_progression 
H-positive risk:  850 839 112 922 344 112 1008 422 164 53 132 42 
H-negative risk:  839 850 1008 922 422 344 112 112 132 164 42 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 64 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
68 
disease_progression 
H-positive risk:  855 842 113 924 340 111 1002 420 165 52 133 43 
H-negative risk:  842 855 1002 924 420 340 111 113 133 165 43 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
69 
disease_progression 
H-positive risk:  852 842 115 926 337 111 1008 417 164 53 131 44 
H-negative risk:  842 852 1008 926 417 337 111 115 131 164 44 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
70 
disease_progression 
H-positive risk:  852 848 114 923 340 112 1009 414 163 52 131 42 
H-negative risk:  848 852 1009 923 414 340 112 114 131 163 42 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
71 
disease_progression 
H-positive risk:  856 854 113 922 336 111 1008 414 164 49 131 42 
H-negative risk:  854 856 1008 922 414 336 111 113 131 164 42 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
72 
disease_progression 
H-positive risk:  862 863 111 927 335 111 1002 399 166 49 132 43 
H-negative risk:  863 862 1002 927 399 335 111 111 132 166 43 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
73 
disease_progression 
H-positive risk:  801 802 102 977 336 101 1063 404 175 50 145 44 
H-negative risk:  802 801 1063 977 404 336 101 102 145 175 44 50 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
100 new agents 
74 
disease_progression 
H-positive risk:  803 800 101 949 369 102 1050 413 170 56 146 41 
H-negative risk:  800 803 1050 949 413 369 102 101 146 170 41 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
75 
disease_progression 
H-positive risk:  802 807 102 948 370 103 1036 421 169 55 148 39 
H-negative risk:  807 802 1036 948 421 370 103 102 148 169 39 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
76 
disease_progression 
H-positive risk:  798 808 105 938 380 104 1043 411 170 56 147 40 
H-negative risk:  808 798 1043 938 411 380 104 105 147 170 40 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
77 
disease_progression 
H-positive risk:  805 805 104 946 378 106 1039 408 168 58 144 39 
H-negative risk:  805 805 1039 946 408 378 106 104 144 168 39 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
57 new agents 
78 
disease_progression 
H-positive risk:  808 807 102 947 373 105 1047 404 165 58 145 39 
H-negative risk:  807 808 1047 947 404 373 105 102 145 165 39 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
79 
disease_progression 
H-positive risk:  797 818 101 946 377 106 1044 399 166 59 145 42 
H-negative risk:  818 797 1044 946 399 377 106 101 145 166 42 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
80 
disease_progression 
H-positive risk:  806 815 99 946 375 105 1044 397 169 60 143 41 
H-negative risk:  815 806 1044 946 397 375 105 99 143 169 41 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
81 
disease_progression 
H-positive risk:  810 814 105 940 376 104 1043 399 167 58 145 39 
H-negative risk:  814 810 1043 940 399 376 104 105 145 167 39 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
82 
disease_progression 
H-positive risk:  810 818 109 935 378 105 1041 397 168 58 142 39 
H-negative risk:  818 810 1041 935 397 378 105 109 142 168 39 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
83 
disease_progression 
H-positive risk:  813 819 111 928 376 106 1039 403 167 58 144 36 
H-negative risk:  819 813 1039 928 403 376 106 111 144 167 36 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
84 
disease_progression 
H-positive risk:  805 821 113 929 379 109 1036 403 167 58 144 36 
H-negative risk:  821 805 1036 929 403 379 109 113 144 167 36 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
85 
disease_progression 
H-positive risk:  767 768 106 987 376 108 1064 404 174 58 151 37 
H-negative risk:  768 767 1064 987 404 376 108 106 151 174 37 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
132 new agents 
86 
disease_progression 
H-positive risk:  770 773 105 971 394 108 1036 423 172 59 149 40 
H-negative risk:  773 770 1036 971 423 394 108 105 149 172 40 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
87 
disease_progression 
H-positive risk:  769 774 103 966 396 107 1042 418 175 60 151 39 
H-negative risk:  774 769 1042 966 418 396 107 103 151 175 39 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
88 
disease_progression 
H-positive risk:  766 776 107 962 391 104 1051 418 175 56 152 42 
H-negative risk:  776 766 1051 962 418 391 104 107 152 175 42 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
89 
disease_progression 
H-positive risk:  768 779 110 963 388 104 1045 424 174 54 150 41 
H-negative risk:  779 768 1045 963 424 388 104 110 150 174 41 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
90 
disease_progression 
H-positive risk:  766 781 108 966 386 105 1044 424 174 56 151 39 
H-negative risk:  781 766 1044 966 424 386 105 108 151 174 39 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
91 
disease_progression 
H-positive risk:  763 778 110 972 383 104 1046 428 174 53 151 38 
H-negative risk:  778 763 1046 972 428 383 104 110 151 174 38 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
92 
disease_progression 
H-positive risk:  767 778 110 964 386 106 1052 423 170 54 151 39 
H-negative risk:  778 767 1052 964 423 386 106 110 151 170 39 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
93 
disease_progression 
H-positive risk:  768 774 109 968 391 103 1051 421 167 55 153 40 
H-negative risk:  774 768 1051 968 421 391 103 109 153 167 40 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
94 
disease_progression 
H-positive risk:  768 782 112 967 387 104 1040 425 169 54 152 40 
H-negative risk:  782 768 1040 967 425 387 104 112 152 169 40 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
46 new agents 
95 
disease_progression 
H-positive risk:  765 782 114 965 388 104 1044 424 169 53 150 42 
H-negative risk:  782 765 1044 965 424 388 104 114 150 169 42 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
96 
disease_progression 
H-positive risk:  768 788 114 965 383 104 1045 420 168 52 152 41 
H-negative risk:  788 768 1045 965 420 383 104 114 152 168 41 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
97 
disease_progression 
H-positive risk:  720 748 105 1006 382 99 1099 421 171 49 158 42 
H-negative risk:  748 720 1099 1006 421 382 99 105 158 171 42 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
125 new agents 
98 
disease_progression 
H-positive risk:  726 743 107 1008 396 98 1097 407 164 58 157 39 
H-negative risk:  743 726 1097 1008 407 396 98 107 157 164 39 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
99 
disease_progression 
H-positive risk:  733 734 107 1016 398 98 1088 406 163 60 156 41 
H-negative risk:  734 733 1088 1016 406 398 98 107 156 163 41 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
100 
disease_progression 
H-positive risk:  740 741 104 1014 396 99 1089 398 163 59 156 41 
H-negative risk:  741 740 1089 1014 398 396 99 104 156 163 41 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
101 
disease_progression 
H-positive risk:  743 739 103 1014 398 98 1090 400 165 56 156 38 
H-negative risk:  739 743 1090 1014 400 398 98 103 156 165 38 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
102 
disease_progression 
H-positive risk:  736 732 102 1026 396 96 1102 397 165 55 154 39 
H-negative risk:  732 736 1102 1026 397 396 96 102 154 165 39 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
103 
disease_progression 
H-positive risk:  738 728 99 1040 394 98 1091 397 163 53 158 41 
H-negative risk:  728 738 1091 1040 397 394 98 99 158 163 41 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
104 
disease_progression 
H-positive risk:  734 720 97 1048 395 99 1092 395 165 56 158 41 
H-negative risk:  720 734 1092 1048 395 395 99 97 158 165 41 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
105 
disease_progression 
H-positive risk:  734 713 96 1052 389 101 1103 392 166 54 158 42 
H-negative risk:  713 734 1103 1052 392 389 101 96 158 166 42 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
106 
disease_progression 
H-positive risk:  733 711 96 1054 383 103 1112 392 162 53 157 44 
H-negative risk:  711 733 1112 1054 392 383 103 96 157 162 44 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
107 
disease_progression 
H-positive risk:  734 718 96 1050 382 102 1102 393 164 51 163 45 
H-negative risk:  718 734 1102 1050 393 382 102 96 163 164 45 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
108 
disease_progression 
H-positive risk:  731 716 95 1054 377 102 1106 394 162 50 167 46 
H-negative risk:  716 731 1106 1054 394 377 102 95 167 162 46 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
109 
disease_progression 
H-positive risk:  689 687 93 1079 382 94 1142 400 170 51 168 45 
H-negative risk:  687 689 1142 1079 400 382 94 93 168 170 45 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
102 new agents 
110 
disease_progression 
H-positive risk:  693 684 92 1064 394 95 1123 414 168 55 172 46 
H-negative risk:  684 693 1123 1064 414 394 95 92 172 168 46 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
111 
disease_progression 
H-positive risk:  692 690 91 1059 407 92 1113 419 166 53 172 46 
H-negative risk:  690 692 1113 1059 419 407 92 91 172 166 46 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
112 
disease_progression 
H-positive risk:  695 695 93 1047 404 88 1117 419 170 53 172 47 
H-negative risk:  695 695 1117 1047 419 404 88 93 172 170 47 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
113 
disease_progression 
H-positive risk:  693 695 93 1051 396 90 1120 423 167 54 170 48 
H-negative risk:  695 693 1120 1051 423 396 90 93 170 167 48 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
114 
disease_progression 
H-positive risk:  692 702 91 1055 394 89 1118 422 165 54 168 50 
H-negative risk:  702 692 1118 1055 422 394 89 91 168 165 50 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
115 
disease_progression 
H-positive risk:  686 707 93 1057 394 90 1122 418 163 52 167 51 
H-negative risk:  707 686 1122 1057 418 394 90 93 167 163 51 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
56 new agents 
116 
disease_progression 
H-positive risk:  684 692 94 1071 392 90 1124 420 162 51 169 51 
H-negative risk:  692 684 1124 1071 420 392 90 94 169 162 51 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
117 
disease_progression 
H-positive risk:  687 693 96 1082 389 93 1111 415 163 48 172 51 
H-negative risk:  693 687 1111 1082 415 389 93 96 172 163 51 48 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
118 
disease_progression 
H-positive risk:  693 698 96 1076 394 96 1113 409 159 48 168 50 
H-negative risk:  698 693 1113 1076 409 394 96 96 168 159 50 48 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
119 
disease_progression 
H-positive risk:  702 698 94 1066 394 99 1117 407 157 46 168 52 
H-negative risk:  698 702 1117 1066 407 394 99 94 168 157 52 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
120 
disease_progression 
H-positive risk:  697 697 96 1077 387 97 1111 413 160 45 167 53 
H-negative risk:  697 697 1111 1077 413 387 97 96 167 160 53 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
121 
disease_progression 
H-positive risk:  653 657 89 1117 379 94 1159 414 169 46 171 52 
H-negative risk:  657 653 1159 1117 414 379 94 89 171 169 52 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
122 
disease_progression 
H-positive risk:  648 653 88 1129 372 95 1156 419 169 48 172 51 
H-negative risk:  653 648 1156 1129 419 372 95 88 172 169 51 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
100 new agents 
123 
disease_progression 
H-positive risk:  654 652 92 1124 377 95 1146 425 168 45 169 53 
H-negative risk:  652 654 1146 1124 425 377 95 92 169 168 53 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
124 
disease_progression 
H-positive risk:  659 647 93 1123 379 95 1147 420 167 47 171 52 
H-negative risk:  647 659 1147 1123 420 379 95 93 171 167 52 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
125 
disease_progression 
H-positive risk:  659 650 92 1129 379 92 1151 411 166 48 171 52 
H-negative risk:  650 659 1151 1129 411 379 92 92 171 166 52 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
126 
disease_progression 
H-positive risk:  663 647 91 1130 377 93 1156 411 162 48 169 53 
H-negative risk:  647 663 1156 1130 411 377 93 91 169 162 53 48 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
127 
disease_progression 
H-positive risk:  666 657 92 1125 366 93 1167 409 158 47 169 51 
H-negative risk:  657 666 1167 1125 409 366 93 92 169 158 51 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
128 
disease_progression 
H-positive risk:  656 663 96 1117 362 93 1172 411 161 48 172 49 
H-negative risk:  663 656 1172 1117 411 362 93 96 172 161 49 48 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
129 
disease_progression 
H-positive risk:  663 662 92 1115 364 92 1172 407 163 50 170 50 
H-negative risk:  662 663 1172 1115 407 364 92 92 170 163 50 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
130 
disease_progression 
H-positive risk:  670 667 90 1114 369 92 1165 405 159 49 167 53 
H-negative risk:  667 670 1165 1114 405 369 92 90 167 159 53 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
103 new agents 
131 
disease_progression 
H-positive risk:  668 670 90 1116 365 93 1162 409 155 52 166 54 
H-negative risk:  670 668 1162 1116 409 365 93 90 166 155 54 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
132 
disease_progression 
H-positive risk:  664 675 91 1119 361 92 1165 405 155 52 168 53 
H-negative risk:  675 664 1165 1119 405 361 92 91 168 155 53 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
133 
disease_progression 
H-positive risk:  669 679 91 1115 365 87 1163 400 158 50 169 54 
H-negative risk:  679 669 1163 1115 400 365 87 91 169 158 54 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
134 
disease_progression 
H-positive risk:  666 678 91 1107 373 86 1155 411 158 54 164 57 
H-negative risk:  678 666 1155 1107 411 373 86 91 164 158 57 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
135 
disease_progression 
H-positive risk:  668 677 89 1111 375 85 1156 409 158 51 167 54 
H-negative risk:  677 668 1156 1111 409 375 85 89 167 158 54 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
136 
disease_progression 
H-positive risk:  664 672 92 1118 371 87 1156 410 158 50 168 54 
H-negative risk:  672 664 1156 1118 410 371 87 92 168 158 54 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
137 
disease_progression 
H-positive risk:  676 668 93 1125 368 89 1151 409 156 48 163 54 
H-negative risk:  668 676 1151 1125 409 368 89 93 163 156 54 48 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
138 
disease_progression 
H-positive risk:  673 671 94 1114 372 90 1154 406 158 47 164 57 
H-negative risk:  671 673 1154 1114 406 372 90 94 164 158 57 47 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
139 
disease_progression 
H-positive risk:  683 663 94 1127 375 90 1132 411 157 49 163 56 
H-negative risk:  663 683 1132 1127 411 375 90 94 163 157 56 49 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
140 
disease_progression 
H-positive risk:  680 662 94 1135 367 91 1138 409 153 48 163 60 
H-negative risk:  662 680 1138 1135 409 367 91 94 163 153 60 48 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
141 
disease_progression 
H-positive risk:  677 668 95 1128 361 93 1146 404 152 49 165 62 
H-negative risk:  668 677 1146 1128 404 361 93 95 165 152 62 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
142 
disease_progression 
H-positive risk:  676 671 94 1126 367 93 1141 402 148 50 170 62 
H-negative risk:  671 676 1141 1126 402 367 93 94 170 148 62 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
143 
disease_progression 
H-positive risk:  676 673 94 1134 366 90 1137 395 154 50 169 62 
H-negative risk:  673 676 1137 1134 395 366 90 94 169 154 62 50 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
144 
disease_progression 
H-positive risk:  676 670 93 1143 370 91 1131 393 150 54 167 62 
H-negative risk:  670 676 1131 1143 393 370 91 93 167 150 62 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
145 
disease_progression 
H-positive risk:  678 671 94 1143 359 90 1141 392 149 56 162 65 
H-negative risk:  671 678 1141 1143 392 359 90 94 162 149 65 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
101 new agents 
146 
disease_progression 
H-positive risk:  683 678 97 1124 375 88 1130 394 149 57 159 66 
H-negative risk:  678 683 1130 1124 394 375 88 97 159 149 66 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
92 new agents 
147 
disease_progression 
H-positive risk:  689 664 97 1128 374 89 1129 400 151 55 158 66 
H-negative risk:  664 689 1129 1128 400 374 89 97 158 151 66 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
148 
disease_progression 
H-positive risk:  687 667 94 1128 368 91 1128 406 149 55 161 66 
H-negative risk:  667 687 1128 1128 406 368 91 94 161 149 66 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
149 
disease_progression 
H-positive risk:  689 665 94 1133 368 94 1129 397 146 57 161 67 
H-negative risk:  665 689 1129 1133 397 368 94 94 161 146 67 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
94 new agents 
150 
disease_progression 
H-positive risk:  690 668 94 1131 368 94 1126 392 148 61 160 68 
H-negative risk:  668 690 1126 1131 392 368 94 94 160 148 68 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
151 
disease_progression 
H-positive risk:  687 672 95 1136 367 94 1117 397 151 61 156 67 
H-negative risk:  672 687 1117 1136 397 367 94 95 156 151 67 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
152 
disease_progression 
H-positive risk:  690 667 94 1145 364 94 1114 400 147 62 157 66 
H-negative risk:  667 690 1114 1145 400 364 94 94 157 147 66 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
153 
disease_progression 
H-positive risk:  691 668 93 1130 372 93 1123 401 149 61 154 65 
H-negative risk:  668 691 1123 1130 401 372 93 93 154 149 65 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
154 
disease_progression 
H-positive risk:  688 674 91 1121 365 94 1125 406 151 60 162 63 
H-negative risk:  674 688 1125 1121 406 365 94 91 162 151 63 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
155 
disease_progression 
H-positive risk:  687 676 89 1117 376 95 1114 408 151 61 165 61 
H-negative risk:  676 687 1114 1117 408 376 95 89 165 151 61 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
156 
disease_progression 
H-positive risk:  690 679 90 1115 372 95 1104 412 153 62 167 61 
H-negative risk:  679 690 1104 1115 412 372 95 90 167 153 61 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
157 
disease_progression 
H-positive risk:  694 678 89 1112 369 92 1104 410 157 60 171 64 
H-negative risk:  678 694 1104 1112 410 369 92 89 171 157 64 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
84 new agents 
158 
disease_progression 
H-positive risk:  692 680 91 1103 379 93 1102 419 152 61 172 56 
H-negative risk:  680 692 1102 1103 419 379 93 91 172 152 56 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 81 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
159 
disease_progression 
H-positive risk:  696 680 89 1096 377 96 1096 425 146 61 178 60 
H-negative risk:  680 696 1096 1096 425 377 96 89 178 146 60 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 79 14 

clinical_engagement 
diagnosis 
demography 
80 new agents 
160 
disease_progression 
H-positive risk:  686 675 91 1112 379 97 1097 420 144 60 178 61 
H-negative risk:  675 686 1097 1112 420 379 97 91 178 144 61 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 79 12 

clinical_engagement 
diagnosis 
demography 
70 new agents 
161 
disease_progression 
H-positive risk:  672 678 90 1116 385 98 1102 418 144 61 176 60 
H-negative risk:  678 672 1102 1116 418 385 98 90 176 144 60 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 80 13 

clinical_engagement 
diagnosis 
demography 
76 new agents 
162 
disease_progression 
H-positive risk:  666 678 89 1119 390 93 1107 417 146 60 178 57 
H-negative risk:  678 666 1107 1119 417 390 93 89 178 146 57 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 79 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
163 
disease_progression 
H-positive risk:  664 679 89 1122 391 91 1109 414 144 64 176 57 
H-negative risk:  679 664 1109 1122 414 391 91 89 176 144 57 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 81 13 

clinical_engagement 
diagnosis 
demography 
107 new agents 
164 
disease_progression 
H-positive risk:  673 677 90 1125 388 90 1107 408 142 63 180 57 
H-negative risk:  677 673 1107 1125 408 388 90 90 180 142 57 63 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 81 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
165 
disease_progression 
H-positive risk:  670 684 93 1122 393 88 1100 408 145 62 181 54 
H-negative risk:  684 670 1100 1122 408 393 88 93 181 145 54 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 84 11 

clinical_engagement 
diagnosis 
demography 
58 new agents 
166 
disease_progression 
H-positive risk:  669 676 93 1132 390 86 1111 400 144 64 180 55 
H-negative risk:  676 669 1111 1132 400 390 86 93 180 144 55 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 83 11 

clinical_engagement 
diagnosis 
demography 
91 new agents 
167 
disease_progression 
H-positive risk:  661 674 94 1127 395 88 1127 397 143 64 177 53 
H-negative risk:  674 661 1127 1127 397 395 88 94 177 143 53 64 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 82 11 

clinical_engagement 
diagnosis 
demography 
74 new agents 
168 
disease_progression 
H-positive risk:  660 667 95 1128 396 87 1127 403 144 63 177 53 
H-negative risk:  667 660 1127 1128 403 396 87 95 177 144 53 63 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 82 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
169 
disease_progression 
H-positive risk:  658 665 94 1136 388 87 1126 407 144 61 180 54 
H-negative risk:  665 658 1126 1136 407 388 87 94 180 144 54 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 83 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
170 
disease_progression 
H-positive risk:  653 653 96 1146 400 83 1110 418 145 64 182 50 
H-negative risk:  653 653 1110 1146 418 400 83 96 182 145 50 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 83 12 

clinical_engagement 
diagnosis 
demography 
84 new agents 
171 
disease_progression 
H-positive risk:  658 652 99 1151 400 79 1110 410 148 64 178 51 
H-negative risk:  652 658 1110 1151 410 400 79 99 178 148 51 64 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 78 12 

clinical_engagement 
diagnosis 
demography 
78 new agents 
172 
disease_progression 
H-positive risk:  661 656 95 1146 393 77 1110 414 150 67 183 48 
H-negative risk:  656 661 1110 1146 414 393 77 95 183 150 48 67 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 78 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
173 
disease_progression 
H-positive risk:  669 655 96 1138 393 77 1109 414 150 68 181 50 
H-negative risk:  655 669 1109 1138 414 393 77 96 181 150 50 68 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 79 12 

clinical_engagement 
diagnosis 
demography 
71 new agents 
174 
disease_progression 
H-positive risk:  679 654 99 1127 398 80 1103 414 150 67 177 52 
H-negative risk:  654 679 1103 1127 414 398 80 99 177 150 52 67 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 79 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
175 
disease_progression 
H-positive risk:  673 660 101 1131 394 81 1100 417 151 65 176 51 
H-negative risk:  660 673 1100 1131 417 394 81 101 176 151 51 65 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 79 12 

clinical_engagement 
diagnosis 
demography 
77 new agents 
176 
disease_progression 
H-positive risk:  681 664 100 1129 393 80 1093 415 147 68 179 51 
H-negative risk:  664 681 1093 1129 415 393 80 100 179 147 51 68 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 77 11 

clinical_engagement 
diagnosis 
demography 
81 new agents 
177 
disease_progression 
H-positive risk:  687 666 99 1123 392 82 1100 408 146 67 183 47 
H-negative risk:  666 687 1100 1123 408 392 82 99 183 146 47 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 80 13 

clinical_engagement 
diagnosis 
demography 
70 new agents 
178 
disease_progression 
H-positive risk:  693 667 102 1123 386 81 1098 407 148 63 184 48 
H-negative risk:  667 693 1098 1123 407 386 81 102 184 148 48 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 81 13 

clinical_engagement 
diagnosis 
demography 
81 new agents 
179 
disease_progression 
H-positive risk:  687 670 105 1130 389 81 1094 411 144 62 180 47 
H-negative risk:  670 687 1094 1130 411 389 81 105 180 144 47 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 82 13 

clinical_engagement 
diagnosis 
demography 
75 new agents 
180 
disease_progression 
H-positive risk:  688 672 109 1135 377 79 1101 404 143 65 178 49 
H-negative risk:  672 688 1101 1135 404 377 79 109 178 143 49 65 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 83 12 

clinical_engagement 
diagnosis 
demography 
77 new agents 
181 
disease_progression 
H-positive risk:  694 667 109 1136 373 79 1089 411 140 71 182 49 
H-negative risk:  667 694 1089 1136 411 373 79 109 182 140 49 71 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 83 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
182 
disease_progression 
H-positive risk:  701 655 106 1139 386 78 1073 422 137 72 182 49 
H-negative risk:  655 701 1073 1139 422 386 78 106 182 137 49 72 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 80 12 

clinical_engagement 
diagnosis 
demography 
85 new agents 
183 
disease_progression 
H-positive risk:  697 651 107 1140 391 79 1075 422 137 69 183 49 
H-negative risk:  651 697 1075 1140 422 391 79 107 183 137 49 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
184 
disease_progression 
H-positive risk:  693 651 108 1136 391 79 1084 421 139 67 181 50 
H-negative risk:  651 693 1084 1136 421 391 79 108 181 139 50 67 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
61 new agents 
185 
disease_progression 
H-positive risk:  689 655 112 1131 396 81 1087 416 138 66 179 50 
H-negative risk:  655 689 1087 1131 416 396 81 112 179 138 50 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
186 
disease_progression 
H-positive risk:  686 655 113 1123 397 81 1090 416 140 64 184 51 
H-negative risk:  655 686 1090 1123 416 397 81 113 184 140 51 64 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 82 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
187 
disease_progression 
H-positive risk:  683 658 115 1122 400 79 1085 416 142 65 183 52 
H-negative risk:  658 683 1085 1122 416 400 79 115 183 142 52 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 83 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
188 
disease_progression 
H-positive risk:  668 664 117 1123 401 79 1099 404 148 63 182 52 
H-negative risk:  664 668 1099 1123 404 401 79 117 182 148 52 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 84 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
189 
disease_progression 
H-positive risk:  660 665 115 1119 401 79 1103 405 151 64 187 51 
H-negative risk:  665 660 1103 1119 405 401 79 115 187 151 51 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 82 13 

clinical_engagement 
diagnosis 
demography 
78 new agents 
190 
disease_progression 
H-positive risk:  657 662 118 1117 403 80 1102 404 153 63 190 51 
H-negative risk:  662 657 1102 1117 404 403 80 118 190 153 51 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 87 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
191 
disease_progression 
H-positive risk:  650 658 116 1115 409 81 1109 406 157 59 190 50 
H-negative risk:  658 650 1109 1115 406 409 81 116 190 157 50 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 87 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
192 
disease_progression 
H-positive risk:  658 653 116 1106 416 80 1104 410 153 62 191 51 
H-negative risk:  653 658 1104 1106 410 416 80 116 191 153 51 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 86 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
193 
disease_progression 
H-positive risk:  658 647 117 1106 410 83 1112 411 151 65 189 51 
H-negative risk:  647 658 1112 1106 411 410 83 117 189 151 51 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 88 13 

clinical_engagement 
diagnosis 
demography 
76 new agents 
194 
disease_progression 
H-positive risk:  654 655 114 1093 423 86 1097 428 151 61 187 51 
H-negative risk:  655 654 1097 1093 428 423 86 114 187 151 51 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 86 13 

clinical_engagement 
diagnosis 
demography 
73 new agents 
195 
disease_progression 
H-positive risk:  650 655 117 1082 421 89 1109 422 152 61 191 51 
H-negative risk:  655 650 1109 1082 422 421 89 117 191 152 51 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 88 13 

clinical_engagement 
diagnosis 
demography 
78 new agents 
196 
disease_progression 
H-positive risk:  655 648 117 1082 427 90 1101 424 149 59 192 56 
H-negative risk:  648 655 1101 1082 424 427 90 117 192 149 56 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 88 14 

clinical_engagement 
diagnosis 
demography 
58 new agents 
197 
disease_progression 
H-positive risk:  659 640 119 1085 423 91 1107 421 147 60 193 55 
H-negative risk:  640 659 1107 1085 421 423 91 119 193 147 55 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 91 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
198 
disease_progression 
H-positive risk:  657 638 122 1092 420 90 1103 420 151 60 190 57 
H-negative risk:  638 657 1103 1092 420 420 90 122 190 151 57 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
199 
disease_progression 
H-positive risk:  655 644 125 1090 426 90 1101 408 152 61 191 57 
H-negative risk:  644 655 1101 1090 408 426 90 125 191 152 57 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
200 
disease_progression 
H-positive risk:  653 645 123 1094 419 90 1097 412 152 61 193 61 
H-negative risk:  645 653 1097 1094 412 419 90 123 193 152 61 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
201 
disease_progression 
H-positive risk:  647 648 125 1101 410 88 1104 410 152 63 193 59 
H-negative risk:  648 647 1104 1101 410 410 88 125 193 152 59 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
95 new agents 
202 
disease_progression 
H-positive risk:  655 643 124 1094 405 90 1107 411 159 59 192 61 
H-negative risk:  643 655 1107 1094 411 405 90 124 192 159 61 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 86 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
203 
disease_progression 
H-positive risk:  662 637 122 1103 404 93 1097 409 159 59 191 64 
H-negative risk:  637 662 1097 1103 409 404 93 122 191 159 64 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 86 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
204 
disease_progression 
H-positive risk:  666 637 124 1104 398 96 1103 405 154 60 186 67 
H-negative risk:  637 666 1103 1104 405 398 96 124 186 154 67 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 87 14 

clinical_engagement 
diagnosis 
demography 
90 new agents 
205 
disease_progression 
H-positive risk:  668 639 123 1095 391 96 1117 406 155 57 186 67 
H-negative risk:  639 668 1117 1095 406 391 96 123 186 155 67 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
206 
disease_progression 
H-positive risk:  667 639 123 1087 394 97 1125 400 152 57 187 72 
H-negative risk:  639 667 1125 1087 400 394 97 123 187 152 72 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
207 
disease_progression 
H-positive risk:  663 636 122 1096 389 101 1122 399 157 60 185 70 
H-negative risk:  636 663 1122 1096 399 389 101 122 185 157 70 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
208 
disease_progression 
H-positive risk:  664 630 124 1103 384 102 1127 397 155 60 180 74 
H-negative risk:  630 664 1127 1103 397 384 102 124 180 155 74 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 91 14 

clinical_engagement 
diagnosis 
demography 
86 new agents 
209 
disease_progression 
H-positive risk:  674 631 124 1095 390 101 1117 394 155 66 177 76 
H-negative risk:  631 674 1117 1095 394 390 101 124 177 155 76 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 88 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
210 
disease_progression 
H-positive risk:  672 636 124 1090 391 101 1115 398 157 65 176 75 
H-negative risk:  636 672 1115 1090 398 391 101 124 176 157 75 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 86 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
211 
disease_progression 
H-positive risk:  670 637 122 1093 394 102 1120 389 160 63 179 71 
H-negative risk:  637 670 1120 1093 389 394 102 122 179 160 71 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 88 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
212 
disease_progression 
H-positive risk:  676 642 120 1081 397 101 1123 388 158 64 178 72 
H-negative risk:  642 676 1123 1081 388 397 101 120 178 158 72 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
213 
disease_progression 
H-positive risk:  673 637 123 1077 404 98 1126 390 155 65 178 74 
H-negative risk:  637 673 1126 1077 390 404 98 123 178 155 74 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
214 
disease_progression 
H-positive risk:  672 640 122 1092 398 100 1122 385 151 67 177 74 
H-negative risk:  640 672 1122 1092 385 398 100 122 177 151 74 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
215 
disease_progression 
H-positive risk:  669 637 124 1093 399 102 1119 389 149 66 179 74 
H-negative risk:  637 669 1119 1093 389 399 102 124 179 149 74 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
216 
disease_progression 
H-positive risk:  660 635 123 1100 406 102 1118 388 146 68 178 76 
H-negative risk:  635 660 1118 1100 388 406 102 123 178 146 76 68 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
217 
disease_progression 
H-positive risk:  652 641 125 1089 415 95 1111 401 148 69 176 78 
H-negative risk:  641 652 1111 1089 401 415 95 125 176 148 78 69 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
91 new agents 
218 
disease_progression 
H-positive risk:  646 640 126 1103 406 92 1116 400 151 66 176 78 
H-negative risk:  640 646 1116 1103 400 406 92 126 176 151 78 66 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
219 
disease_progression 
H-positive risk:  644 638 125 1108 412 91 1108 405 151 66 177 75 
H-negative risk:  638 644 1108 1108 405 412 91 125 177 151 75 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 86 14 

clinical_engagement 
diagnosis 
demography 
82 new agents 
220 
disease_progression 
H-positive risk:  647 640 125 1105 407 90 1116 399 153 64 180 74 
H-negative risk:  640 647 1116 1105 399 407 90 125 180 153 74 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 87 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
221 
disease_progression 
H-positive risk:  655 641 124 1099 406 90 1115 397 156 62 182 73 
H-negative risk:  641 655 1115 1099 397 406 90 124 182 156 73 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 86 13 

clinical_engagement 
diagnosis 
demography 
80 new agents 
222 
disease_progression 
H-positive risk:  651 641 126 1092 411 90 1123 393 160 61 180 72 
H-negative risk:  641 651 1123 1092 393 411 90 126 180 160 72 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
81 new agents 
223 
disease_progression 
H-positive risk:  656 640 126 1093 405 87 1129 388 161 61 182 72 
H-negative risk:  640 656 1129 1093 388 405 87 126 182 161 72 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
79 new agents 
224 
disease_progression 
H-positive risk:  654 638 124 1098 406 87 1130 391 162 59 183 68 
H-negative risk:  638 654 1130 1098 391 406 87 124 183 162 68 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 84 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
225 
disease_progression 
H-positive risk:  660 640 125 1097 417 83 1113 395 162 60 183 65 
H-negative risk:  640 660 1113 1097 395 417 83 125 183 162 65 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
226 
disease_progression 
H-positive risk:  654 644 128 1094 416 79 1107 408 164 58 183 65 
H-negative risk:  644 654 1107 1094 408 416 79 128 183 164 65 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 83 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
227 
disease_progression 
H-positive risk:  653 642 133 1095 419 79 1105 406 165 55 181 67 
H-negative risk:  642 653 1105 1095 406 419 79 133 181 165 67 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 85 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
228 
disease_progression 
H-positive risk:  651 647 133 1095 415 77 1116 397 169 55 179 66 
H-negative risk:  647 651 1116 1095 397 415 77 133 179 169 66 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 82 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
229 
disease_progression 
H-positive risk:  649 647 132 1087 427 77 1112 401 168 55 176 69 
H-negative risk:  647 649 1112 1087 401 427 77 132 176 168 69 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 79 12 

clinical_engagement 
diagnosis 
demography 
100 new agents 
230 
disease_progression 
H-positive risk:  637 656 131 1087 426 79 1121 388 170 53 183 69 
H-negative risk:  656 637 1121 1087 388 426 79 131 183 170 69 53 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 75 12 

clinical_engagement 
diagnosis 
demography 
70 new agents 
231 
disease_progression 
H-positive risk:  633 654 132 1092 425 76 1127 387 173 53 180 68 
H-negative risk:  654 633 1127 1092 387 425 76 132 180 173 68 53 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 68 13 

clinical_engagement 
diagnosis 
demography 
77 new agents 
232 
disease_progression 
H-positive risk:  626 653 129 1090 427 78 1134 392 176 53 178 64 
H-negative risk:  653 626 1134 1090 392 427 78 129 178 176 64 53 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 69 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
233 
disease_progression 
H-positive risk:  618 651 129 1086 431 81 1125 402 181 54 182 60 
H-negative risk:  651 618 1125 1086 402 431 81 129 182 181 60 54 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
90 new agents 
234 
disease_progression 
H-positive risk:  629 651 126 1081 436 82 1121 403 178 54 177 62 
H-negative risk:  651 629 1121 1081 403 436 82 126 177 178 62 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
235 
disease_progression 
H-positive risk:  630 648 122 1082 439 85 1121 401 177 56 176 63 
H-negative risk:  648 630 1121 1082 401 439 85 122 176 177 63 56 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
236 
disease_progression 
H-positive risk:  637 651 120 1074 434 83 1125 401 177 56 178 64 
H-negative risk:  651 637 1125 1074 401 434 83 120 178 177 64 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
237 
disease_progression 
H-positive risk:  644 658 121 1070 440 84 1117 402 172 53 179 60 
H-negative risk:  658 644 1117 1070 402 440 84 121 179 172 60 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 78 14 

clinical_engagement 
diagnosis 
demography 
87 new agents 
238 
disease_progression 
H-positive risk:  639 656 119 1077 433 86 1118 406 171 53 179 63 
H-negative risk:  656 639 1118 1077 406 433 86 119 179 171 63 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 80 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
239 
disease_progression 
H-positive risk:  637 661 117 1073 436 87 1127 398 171 53 179 61 
H-negative risk:  661 637 1127 1073 398 436 87 117 179 171 61 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 78 11 

clinical_engagement 
diagnosis 
demography 
78 new agents 
240 
disease_progression 
H-positive risk:  647 663 117 1076 433 88 1121 388 172 53 179 63 
H-negative risk:  663 647 1121 1076 388 433 88 117 179 172 63 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 80 12 

clinical_engagement 
diagnosis 
demography 
92 new agents 
241 
disease_progression 
H-positive risk:  642 658 120 1068 444 90 1119 397 169 54 178 61 
H-negative risk:  658 642 1119 1068 397 444 90 120 178 169 61 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 83 15 

clinical_engagement 
diagnosis 
demography 
87 new agents 
242 
disease_progression 
H-positive risk:  645 661 119 1070 443 92 1111 400 169 50 174 66 
H-negative risk:  661 645 1111 1070 400 443 92 119 174 169 66 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 86 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
243 
disease_progression 
H-positive risk:  638 659 119 1081 437 92 1107 405 169 51 177 65 
H-negative risk:  659 638 1107 1081 405 437 92 119 177 169 65 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
244 
disease_progression 
H-positive risk:  635 659 115 1083 440 91 1109 403 170 51 177 67 
H-negative risk:  659 635 1109 1083 403 440 91 115 177 170 67 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
245 
disease_progression 
H-positive risk:  642 657 118 1090 440 94 1101 400 169 49 174 66 
H-negative risk:  657 642 1101 1090 400 440 94 118 174 169 66 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
246 
disease_progression 
H-positive risk:  638 658 119 1086 443 92 1110 396 168 50 173 67 
H-negative risk:  658 638 1110 1086 396 443 92 119 173 168 67 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
247 
disease_progression 
H-positive risk:  647 664 117 1086 434 97 1104 398 167 49 171 66 
H-negative risk:  664 647 1104 1086 398 434 97 117 171 167 66 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
248 
disease_progression 
H-positive risk:  642 660 117 1092 430 100 1107 402 162 51 171 66 
H-negative risk:  660 642 1107 1092 402 430 100 117 171 162 66 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
249 
disease_progression 
H-positive risk:  653 659 115 1097 421 102 1103 399 161 51 173 66 
H-negative risk:  659 653 1103 1097 399 421 102 115 173 161 66 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
250 
disease_progression 
H-positive risk:  653 655 116 1102 415 102 1103 400 161 52 175 66 
H-negative risk:  655 653 1103 1102 400 415 102 116 175 161 66 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
251 
disease_progression 
H-positive risk:  656 664 120 1090 420 101 1094 401 159 52 176 67 
H-negative risk:  664 656 1094 1090 401 420 101 120 176 159 67 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
252 
disease_progression 
H-positive risk:  650 662 119 1100 410 100 1103 401 161 53 174 67 
H-negative risk:  662 650 1103 1100 401 410 100 119 174 161 67 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
253 
disease_progression 
H-positive risk:  643 661 120 1099 409 98 1105 406 165 52 175 67 
H-negative risk:  661 643 1105 1099 406 409 98 120 175 165 67 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
254 
disease_progression 
H-positive risk:  642 665 118 1102 405 98 1100 403 165 53 177 72 
H-negative risk:  665 642 1100 1102 403 405 98 118 177 165 72 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
255 
disease_progression 
H-positive risk:  638 668 118 1107 408 98 1102 397 161 57 171 75 
H-negative risk:  668 638 1102 1107 397 408 98 118 171 161 75 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
256 
disease_progression 
H-positive risk:  633 668 119 1111 412 95 1096 398 162 62 169 75 
H-negative risk:  668 633 1096 1111 398 412 95 119 169 162 75 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
257 
disease_progression 
H-positive risk:  628 676 119 1108 419 94 1090 396 161 63 170 76 
H-negative risk:  676 628 1090 1108 396 419 94 119 170 161 76 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
258 
disease_progression 
H-positive risk:  634 672 121 1110 420 95 1090 389 163 62 171 73 
H-negative risk:  672 634 1090 1110 389 420 95 121 171 163 73 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
259 
disease_progression 
H-positive risk:  629 676 118 1116 421 95 1085 395 164 59 171 71 
H-negative risk:  676 629 1085 1116 395 421 95 118 171 164 71 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
260 
disease_progression 
H-positive risk:  632 675 116 1122 420 96 1082 386 161 66 173 71 
H-negative risk:  675 632 1082 1122 386 420 96 116 173 161 71 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
261 
disease_progression 
H-positive risk:  638 671 115 1115 429 95 1083 383 160 66 174 71 
H-negative risk:  671 638 1083 1115 383 429 95 115 174 160 71 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
262 
disease_progression 
H-positive risk:  646 669 116 1119 427 94 1079 378 160 65 176 71 
H-negative risk:  669 646 1079 1119 378 427 94 116 176 160 71 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
263 
disease_progression 
H-positive risk:  643 663 115 1130 419 95 1083 383 161 66 172 70 
H-negative risk:  663 643 1083 1130 383 419 95 115 172 161 70 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
264 
disease_progression 
H-positive risk:  642 662 112 1130 419 95 1084 390 163 66 172 65 
H-negative risk:  662 642 1084 1130 390 419 95 112 172 163 65 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
265 
disease_progression 
H-positive risk:  649 659 112 1126 422 97 1077 394 162 67 171 64 
H-negative risk:  659 649 1077 1126 394 422 97 112 171 162 64 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
266 
disease_progression 
H-positive risk:  654 658 113 1132 419 99 1066 395 166 69 165 64 
H-negative risk:  658 654 1066 1132 395 419 99 113 165 166 64 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
267 
disease_progression 
H-positive risk:  664 652 109 1131 424 101 1057 395 165 70 168 64 
H-negative risk:  652 664 1057 1131 395 424 101 109 168 165 64 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
268 
disease_progression 
H-positive risk:  664 655 110 1119 435 101 1061 389 165 71 166 64 
H-negative risk:  655 664 1061 1119 389 435 101 110 166 165 64 71 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
269 
disease_progression 
H-positive risk:  665 653 108 1129 429 100 1070 385 162 66 170 63 
H-negative risk:  653 665 1070 1129 385 429 100 108 170 162 63 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
270 
disease_progression 
H-positive risk:  666 649 109 1135 422 102 1071 387 161 63 171 64 
H-negative risk:  649 666 1071 1135 387 422 102 109 171 161 64 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
271 
disease_progression 
H-positive risk:  655 644 109 1139 425 104 1074 396 159 64 167 64 
H-negative risk:  644 655 1074 1139 396 425 104 109 167 159 64 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
272 
disease_progression 
H-positive risk:  652 643 111 1145 428 105 1071 397 158 59 167 64 
H-negative risk:  643 652 1071 1145 397 428 105 111 167 158 64 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
273 
disease_progression 
H-positive risk:  659 638 111 1145 427 105 1064 404 157 59 167 64 
H-negative risk:  638 659 1064 1145 404 427 105 111 167 157 64 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
274 
disease_progression 
H-positive risk:  664 641 107 1133 429 106 1067 403 155 60 171 64 
H-negative risk:  641 664 1067 1133 403 429 106 107 171 155 64 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
275 
disease_progression 
H-positive risk:  671 635 107 1131 427 112 1065 404 155 60 169 64 
H-negative risk:  635 671 1065 1131 404 427 112 107 169 155 64 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
276 
disease_progression 
H-positive risk:  671 642 105 1130 429 110 1058 406 157 57 169 66 
H-negative risk:  642 671 1058 1130 406 429 110 105 169 157 66 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
277 
disease_progression 
H-positive risk:  673 645 108 1127 431 107 1061 400 158 58 170 62 
H-negative risk:  645 673 1061 1127 400 431 107 108 170 158 62 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
92 new agents 
278 
disease_progression 
H-positive risk:  679 643 109 1122 423 108 1070 396 155 59 170 66 
H-negative risk:  643 679 1070 1122 396 423 108 109 170 155 66 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
90 new agents 
279 
disease_progression 
H-positive risk:  676 652 109 1123 420 105 1064 402 155 60 168 66 
H-negative risk:  652 676 1064 1123 402 420 105 109 168 155 66 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
280 
disease_progression 
H-positive risk:  677 650 106 1125 420 107 1042 415 156 61 173 68 
H-negative risk:  650 677 1042 1125 415 420 107 106 173 156 68 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
281 
disease_progression 
H-positive risk:  677 648 104 1123 412 104 1044 425 155 62 178 68 
H-negative risk:  648 677 1044 1123 425 412 104 104 178 155 68 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
282 
disease_progression 
H-positive risk:  681 650 102 1123 411 104 1044 424 156 60 174 71 
H-negative risk:  650 681 1044 1123 424 411 104 102 174 156 71 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
283 
disease_progression 
H-positive risk:  678 648 104 1119 411 104 1045 427 161 58 173 72 
H-negative risk:  648 678 1045 1119 427 411 104 104 173 161 72 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
284 
disease_progression 
H-positive risk:  681 649 107 1121 409 103 1043 422 159 59 171 76 
H-negative risk:  649 681 1043 1121 422 409 103 107 171 159 76 59 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
285 
disease_progression 
H-positive risk:  681 651 105 1118 414 101 1043 421 157 62 173 74 
H-negative risk:  651 681 1043 1118 421 414 101 105 173 157 74 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
286 
disease_progression 
H-positive risk:  684 644 106 1121 413 104 1048 416 158 61 171 74 
H-negative risk:  644 684 1048 1121 416 413 104 106 171 158 74 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
83 new agents 
287 
disease_progression 
H-positive risk:  683 643 107 1128 407 103 1056 410 159 63 164 77 
H-negative risk:  643 683 1056 1128 410 407 103 107 164 159 77 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
49 new agents 
288 
disease_progression 
H-positive risk:  677 643 108 1126 412 104 1056 413 156 65 164 76 
H-negative risk:  643 677 1056 1126 413 412 104 108 164 156 76 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
289 
disease_progression 
H-positive risk:  676 654 107 1121 412 103 1054 414 156 67 161 75 
H-negative risk:  654 676 1054 1121 414 412 103 107 161 156 75 67 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
290 
disease_progression 
H-positive risk:  687 655 109 1116 415 102 1037 423 153 66 162 75 
H-negative risk:  655 687 1037 1116 423 415 102 109 162 153 75 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
96 new agents 
291 
disease_progression 
H-positive risk:  683 661 109 1105 423 103 1030 430 151 67 160 78 
H-negative risk:  661 683 1030 1105 430 423 103 109 160 151 78 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
292 
disease_progression 
H-positive risk:  673 668 109 1101 421 101 1040 429 153 68 156 81 
H-negative risk:  668 673 1040 1101 429 421 101 109 156 153 81 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
293 
disease_progression 
H-positive risk:  670 664 113 1112 408 101 1053 423 151 69 153 83 
H-negative risk:  664 670 1053 1112 423 408 101 113 153 151 83 69 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
56 new agents 
294 
disease_progression 
H-positive risk:  668 666 112 1116 407 100 1052 425 148 70 150 86 
H-negative risk:  666 668 1052 1116 425 407 100 112 150 148 86 70 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
295 
disease_progression 
H-positive risk:  672 663 113 1113 410 101 1045 432 147 68 151 85 
H-negative risk:  663 672 1045 1113 432 410 101 113 151 147 85 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
296 
disease_progression 
H-positive risk:  674 663 110 1111 404 103 1042 436 150 67 155 85 
H-negative risk:  663 674 1042 1111 436 404 103 110 155 150 85 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
297 
disease_progression 
H-positive risk:  674 674 111 1100 407 102 1046 437 150 63 153 83 
H-negative risk:  674 674 1046 1100 437 407 102 111 153 150 83 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
298 
disease_progression 
H-positive risk:  675 683 113 1085 409 97 1063 429 148 61 156 81 
H-negative risk:  683 675 1063 1085 429 409 97 113 156 148 81 61 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
299 
disease_progression 
H-positive risk:  685 677 113 1087 413 98 1049 436 151 60 158 73 
H-negative risk:  677 685 1049 1087 436 413 98 113 158 151 73 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
300 
disease_progression 
H-positive risk:  687 680 114 1078 415 101 1052 438 148 60 156 71 
H-negative risk:  680 687 1052 1078 438 415 101 114 156 148 71 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
301 
disease_progression 
H-positive risk:  688 678 117 1078 411 103 1057 436 147 60 152 73 
H-negative risk:  678 688 1057 1078 436 411 103 117 152 147 73 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
302 
disease_progression 
H-positive risk:  687 669 115 1078 419 105 1055 444 147 59 151 71 
H-negative risk:  669 687 1055 1078 444 419 105 115 151 147 71 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
303 
disease_progression 
H-positive risk:  676 674 117 1088 416 108 1053 442 146 61 144 75 
H-negative risk:  674 676 1053 1088 442 416 108 117 144 146 75 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
304 
disease_progression 
H-positive risk:  678 680 118 1086 415 106 1059 435 147 60 145 71 
H-negative risk:  680 678 1059 1086 435 415 106 118 145 147 71 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
305 
disease_progression 
H-positive risk:  678 682 118 1082 419 106 1047 442 147 59 149 71 
H-negative risk:  682 678 1047 1082 442 419 106 118 149 147 71 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
306 
disease_progression 
H-positive risk:  678 682 122 1077 421 106 1044 440 149 58 151 72 
H-negative risk:  682 678 1044 1077 440 421 106 122 151 149 72 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
307 
disease_progression 
H-positive risk:  680 681 122 1071 424 107 1048 439 147 59 151 71 
H-negative risk:  681 680 1048 1071 439 424 107 122 151 147 71 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
308 
disease_progression 
H-positive risk:  682 684 123 1067 424 108 1049 438 147 60 147 71 
H-negative risk:  684 682 1049 1067 438 424 108 123 147 147 71 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
309 
disease_progression 
H-positive risk:  682 682 122 1065 428 108 1055 435 146 61 145 71 
H-negative risk:  682 682 1055 1065 435 428 108 122 145 146 71 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
310 
disease_progression 
H-positive risk:  678 692 121 1057 434 107 1060 433 145 59 144 70 
H-negative risk:  692 678 1060 1057 433 434 107 121 144 145 70 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
311 
disease_progression 
H-positive risk:  683 692 121 1054 428 107 1051 442 148 57 145 72 
H-negative risk:  692 683 1051 1054 442 428 107 121 145 148 72 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
312 
disease_progression 
H-positive risk:  698 687 122 1047 434 107 1036 449 146 55 146 73 
H-negative risk:  687 698 1036 1047 449 434 107 122 146 146 73 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
313 
disease_progression 
H-positive risk:  692 689 123 1049 428 109 1035 446 150 55 146 78 
H-negative risk:  689 692 1035 1049 446 428 109 123 146 150 78 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
314 
disease_progression 
H-positive risk:  689 682 121 1057 423 109 1045 439 153 58 150 74 
H-negative risk:  682 689 1045 1057 439 423 109 121 150 153 74 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
97 new agents 
315 
disease_progression 
H-positive risk:  696 682 120 1059 422 108 1039 439 152 57 150 76 
H-negative risk:  682 696 1039 1059 439 422 108 120 150 152 76 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
316 
disease_progression 
H-positive risk:  694 678 121 1062 421 111 1041 441 151 57 150 73 
H-negative risk:  678 694 1041 1062 441 421 111 121 150 151 73 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
317 
disease_progression 
H-positive risk:  693 676 118 1069 421 109 1044 441 144 59 150 76 
H-negative risk:  676 693 1044 1069 441 421 109 118 150 144 76 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
318 
disease_progression 
H-positive risk:  693 678 113 1067 423 105 1046 438 146 59 154 78 
H-negative risk:  678 693 1046 1067 438 423 105 113 154 146 78 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
97 new agents 
319 
disease_progression 
H-positive risk:  698 677 111 1069 418 104 1052 432 144 62 158 75 
H-negative risk:  677 698 1052 1069 432 418 104 111 158 144 75 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
320 
disease_progression 
H-positive risk:  697 685 113 1058 415 104 1058 430 146 62 160 72 
H-negative risk:  685 697 1058 1058 430 415 104 113 160 146 72 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
321 
disease_progression 
H-positive risk:  689 684 113 1063 416 106 1053 436 146 63 164 67 
H-negative risk:  684 689 1053 1063 436 416 106 113 164 146 67 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
322 
disease_progression 
H-positive risk:  687 693 114 1060 408 103 1058 438 149 64 160 66 
H-negative risk:  693 687 1058 1060 438 408 103 114 160 149 66 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
323 
disease_progression 
H-positive risk:  691 691 115 1064 400 101 1065 434 149 62 163 65 
H-negative risk:  691 691 1065 1064 434 400 101 115 163 149 65 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
324 
disease_progression 
H-positive risk:  692 695 116 1072 393 104 1059 433 148 59 163 66 
H-negative risk:  695 692 1059 1072 433 393 104 116 163 148 66 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
90 new agents 
325 
disease_progression 
H-positive risk:  696 698 115 1067 395 109 1053 431 144 61 163 68 
H-negative risk:  698 696 1053 1067 431 395 109 115 163 144 68 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
326 
disease_progression 
H-positive risk:  699 703 117 1060 390 112 1064 424 144 60 160 67 
H-negative risk:  703 699 1064 1060 424 390 112 117 160 144 67 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
327 
disease_progression 
H-positive risk:  699 689 116 1071 390 109 1067 426 145 60 162 66 
H-negative risk:  689 699 1067 1071 426 390 109 116 162 145 66 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
328 
disease_progression 
H-positive risk:  704 688 119 1067 391 108 1064 425 147 59 162 66 
H-negative risk:  688 704 1064 1067 425 391 108 119 162 147 66 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
329 
disease_progression 
H-positive risk:  711 693 123 1056 388 107 1061 425 148 60 164 64 
H-negative risk:  693 711 1061 1056 425 388 107 123 164 148 64 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
330 
disease_progression 
H-positive risk:  718 688 122 1066 376 110 1063 421 149 60 164 63 
H-negative risk:  688 718 1063 1066 421 376 110 122 164 149 63 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
331 
disease_progression 
H-positive risk:  722 690 121 1065 377 105 1068 418 151 58 161 64 
H-negative risk:  690 722 1068 1065 418 377 105 121 161 151 64 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
332 
disease_progression 
H-positive risk:  722 692 121 1066 379 110 1061 418 148 56 164 63 
H-negative risk:  692 722 1061 1066 418 379 110 121 164 148 63 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
333 
disease_progression 
H-positive risk:  714 690 121 1072 377 110 1069 415 146 55 165 66 
H-negative risk:  690 714 1069 1072 415 377 110 121 165 146 66 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
334 
disease_progression 
H-positive risk:  712 692 118 1057 378 110 1074 421 149 55 167 67 
H-negative risk:  692 712 1074 1057 421 378 110 118 167 149 67 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
335 
disease_progression 
H-positive risk:  715 688 119 1065 378 112 1071 419 149 55 164 65 
H-negative risk:  688 715 1071 1065 419 378 112 119 164 149 65 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
82 new agents 
336 
disease_progression 
H-positive risk:  712 686 113 1070 386 115 1074 412 146 57 165 64 
H-negative risk:  686 712 1074 1070 412 386 115 113 165 146 64 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
337 
disease_progression 
H-positive risk:  708 691 111 1067 391 114 1080 410 146 56 164 62 
H-negative risk:  691 708 1080 1067 410 391 114 111 164 146 62 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 81 32 

clinical_engagement 
diagnosis 
demography 
64 new agents 
338 
disease_progression 
H-positive risk:  701 688 109 1072 387 113 1095 411 144 56 163 61 
H-negative risk:  688 701 1095 1072 411 387 113 109 163 144 61 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
339 
disease_progression 
H-positive risk:  692 693 109 1067 388 112 1108 408 142 56 160 65 
H-negative risk:  693 692 1108 1067 408 388 112 109 160 142 65 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
83 new agents 
340 
disease_progression 
H-positive risk:  689 699 110 1065 389 113 1104 405 144 59 158 65 
H-negative risk:  699 689 1104 1065 405 389 113 110 158 144 65 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
341 
disease_progression 
H-positive risk:  686 705 110 1062 390 111 1106 405 142 59 159 65 
H-negative risk:  705 686 1106 1062 405 390 111 110 159 142 65 59 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 85 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
342 
disease_progression 
H-positive risk:  695 703 107 1064 389 111 1106 401 142 56 162 64 
H-negative risk:  703 695 1106 1064 401 389 111 107 162 142 64 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 83 34 

clinical_engagement 
diagnosis 
demography 
76 new agents 
343 
disease_progression 
H-positive risk:  696 707 106 1062 391 111 1102 404 142 51 161 67 
H-negative risk:  707 696 1102 1062 404 391 111 106 161 142 67 51 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 86 35 

clinical_engagement 
diagnosis 
demography 
68 new agents 
344 
disease_progression 
H-positive risk:  693 722 105 1051 392 109 1102 405 141 50 162 68 
H-negative risk:  722 693 1102 1051 405 392 109 105 162 141 68 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 86 34 

clinical_engagement 
diagnosis 
demography 
80 new agents 
345 
disease_progression 
H-positive risk:  699 727 104 1045 393 108 1096 408 141 50 161 68 
H-negative risk:  727 699 1096 1045 408 393 108 104 161 141 68 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 88 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
346 
disease_progression 
H-positive risk:  702 724 103 1041 394 109 1098 410 140 50 160 69 
H-negative risk:  724 702 1098 1041 410 394 109 103 160 140 69 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 88 32 

clinical_engagement 
diagnosis 
demography 
88 new agents 
347 
disease_progression 
H-positive risk:  707 720 106 1045 391 107 1104 405 142 48 158 67 
H-negative risk:  720 707 1104 1045 405 391 107 106 158 142 67 48 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
348 
disease_progression 
H-positive risk:  708 727 105 1039 394 106 1105 399 142 50 159 66 
H-negative risk:  727 708 1105 1039 399 394 106 105 159 142 66 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
349 
disease_progression 
H-positive risk:  706 722 103 1040 403 104 1106 397 144 47 161 67 
H-negative risk:  722 706 1106 1040 397 403 104 103 161 144 67 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
350 
disease_progression 
H-positive risk:  697 720 101 1040 396 100 1123 401 145 46 165 66 
H-negative risk:  720 697 1123 1040 401 396 100 101 165 145 66 46 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
351 
disease_progression 
H-positive risk:  694 719 100 1044 398 101 1120 402 143 48 166 65 
H-negative risk:  719 694 1120 1044 402 398 101 100 166 143 65 48 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
352 
disease_progression 
H-positive risk:  698 712 100 1052 401 105 1113 399 141 48 164 67 
H-negative risk:  712 698 1113 1052 399 401 105 100 164 141 67 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
353 
disease_progression 
H-positive risk:  694 708 101 1061 406 106 1108 395 141 48 162 70 
H-negative risk:  708 694 1108 1061 395 406 106 101 162 141 70 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
354 
disease_progression 
H-positive risk:  694 706 103 1060 412 106 1116 385 141 48 158 71 
H-negative risk:  706 694 1116 1060 385 412 106 103 158 141 71 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
355 
disease_progression 
H-positive risk:  692 704 103 1059 402 108 1119 393 144 49 156 71 
H-negative risk:  704 692 1119 1059 393 402 108 103 156 144 71 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
356 
disease_progression 
H-positive risk:  690 691 105 1069 411 109 1112 394 146 49 155 69 
H-negative risk:  691 690 1112 1069 394 411 109 105 155 146 69 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
357 
disease_progression 
H-positive risk:  687 690 103 1068 412 111 1122 389 147 47 158 66 
H-negative risk:  690 687 1122 1068 389 412 111 103 158 147 66 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
358 
disease_progression 
H-positive risk:  688 683 103 1071 406 109 1123 392 148 49 160 68 
H-negative risk:  683 688 1123 1071 392 406 109 103 160 148 68 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
359 
disease_progression 
H-positive risk:  687 683 101 1071 413 109 1116 396 150 48 158 68 
H-negative risk:  683 687 1116 1071 396 413 109 101 158 150 68 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
360 
disease_progression 
H-positive risk:  694 678 103 1066 407 111 1116 406 150 46 155 68 
H-negative risk:  678 694 1116 1066 406 407 111 103 155 150 68 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
Time difference of 21.16219 mins
This is task 29
date
